Radioprotection
JS Greenberger - In vivo, 2009 - iv.iiarjournals.org
JS Greenberger
In vivo, 2009•iv.iiarjournals.orgOver 40% of cancer patients will require radiation therapy during management of their
disease. Although radiation therapy improves the survival of a significant number of cancer
patients, both acute radiation toxicity (which manifests during a course of clinical
radiotherapy or shortly thereafter), and late toxicity (developing months to years after
completion of radiotherapy) compromise overall outcomes for successfully treated cancer
patients.
disease. Although radiation therapy improves the survival of a significant number of cancer
patients, both acute radiation toxicity (which manifests during a course of clinical
radiotherapy or shortly thereafter), and late toxicity (developing months to years after
completion of radiotherapy) compromise overall outcomes for successfully treated cancer
patients.
Over 40% of cancer patients will require radiation therapy during management of their disease. Although radiation therapy improves the survival of a significant number of cancer patients, both acute radiation toxicity (which manifests during a course of clinical radiotherapy or shortly thereafter), and late toxicity (developing months to years after completion of radiotherapy) compromise overall outcomes for successfully treated cancer patients.
iv.iiarjournals.org